Tecan announces platform development partnership with DiaSorin

Tecan has announced a new platform development partnership with in vitro diagnostic specialist DiaSorin.

Under the terms of the agreement, the companies will collaborate on an initiative that will see DiaSorin make use of Tecan's Fluent laboratory automation solution as its nucleic acid extraction platform.

Tecan's platform will be used in combination with the DiaSorin Liaison MDX polymerase chain reaction (PCR) system to provide customers with a complete sample-to-result system for molecular diagnostic applications.

The Fluent platform will be supplied through the company's Tecan Partnering division and will be tailored for use with DiaSorin's extraction chemistry, as well as the automated PCR setup of the Liaison MDX 96-well disc.

Tecan said: "Fluent breaks new ground, delivering more capacity and increased speed. The platform provides exceptional precision, throughput and walkaway time."

The firm specialises in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector, with a sales and service network spanning 52 countries.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.